These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [The yin yang of inflammation: inducible and constitutive cyclooxygenase. Nimesulide and selective inhibitors of inducible cyclooxygenase]. Cirino G; Coppini A; Bigini C; Mitchell JA Eur Rev Med Pharmacol Sci; 1998; 2(3 Suppl 1):1-8. PubMed ID: 10887524 [No Abstract] [Full Text] [Related]
4. Comparison of antipyretic effect of nimesulide and paracetamol in children attending a secondary level hospital. Kapoor SK; Sharma J; Batra B; Paul E; Anand K; Sharma D Indian Pediatr; 2002 May; 39(5):473-7. PubMed ID: 12037280 [No Abstract] [Full Text] [Related]
5. [Nimesulide: a lower risk treatment in rheumatic diseases]. Trnavský K Vnitr Lek; 2004 Feb; 50(2):157-62. PubMed ID: 15077593 [TBL] [Abstract][Full Text] [Related]
6. Raising the safety bar--the FDA's coxib meeting. Okie S N Engl J Med; 2005 Mar; 352(13):1283-5. PubMed ID: 15800221 [No Abstract] [Full Text] [Related]
7. Outfoxing pathways of pain. 'COX-2' drugs are easier on stomach. Brink S US News World Rep; 1998 Dec; 125(23):62. PubMed ID: 10345496 [No Abstract] [Full Text] [Related]
8. From the Food and Drug Administration. Nightingale SL JAMA; 1999 Mar; 281(9):786. PubMed ID: 10070983 [No Abstract] [Full Text] [Related]
9. Evaluation of efficacy of nizer versus nimesulide tablets in otitis media. Dasgupta KS; Deshpande AS; Vedi JN; Patel S J Indian Med Assoc; 2002 Oct; 100(10):619. PubMed ID: 12452517 [TBL] [Abstract][Full Text] [Related]
10. From the Food and Drug Administration. Henney JE JAMA; 2000 Mar; 283(9):1131. PubMed ID: 10703765 [No Abstract] [Full Text] [Related]
11. Comment on efficacy of rofecoxib and nimesulide in controlling post-extraction pain in oral surgery: a randomised comparative study. Villa G Curr Med Res Opin; 2004 Apr; 20(4):573-4; author reply 574. PubMed ID: 15119995 [No Abstract] [Full Text] [Related]
12. Drug safety. FDA panel urges caution on many anti-inflammatory drugs. Couzin J Science; 2005 Feb; 307(5713):1183-5. PubMed ID: 15731414 [No Abstract] [Full Text] [Related]
13. [Nimesulide - a non-steroidal anti-inflammatory drug, a preferential cyclooxygenase-2 inhibitor]. Bennett A; Vila D Vutr Boles; 2000; 32(1):33-6. PubMed ID: 11195195 [TBL] [Abstract][Full Text] [Related]
14. The pain game. Wadman M Nature; 2007 Jul; 448(7152):400-1. PubMed ID: 17653159 [No Abstract] [Full Text] [Related]
15. Use of a cyclo-oxygenase type-2-selective non-steroidal anti-inflammatory agent to prevent preterm delivery. Sawdy R; Slater D; Fisk N; Edmonds DK; Bennett P Lancet; 1997 Jul; 350(9073):265-6. PubMed ID: 9242810 [No Abstract] [Full Text] [Related]
16. Nimesulide -- a multifactorial approach to inflammation and pain: scientific and clinical consensus. Rainsford KD; Curr Med Res Opin; 2006 Jun; 22(6):1161-70. PubMed ID: 16846549 [TBL] [Abstract][Full Text] [Related]
18. Non-steroidal anti-inflammatory drugs in orofacial pain management--an update. van der Bijl P; van der Bijl P SADJ; 2002 Aug; 57(8):328-31. PubMed ID: 12428528 [No Abstract] [Full Text] [Related]
19. [Current post-marketing information. Effects and adverse effects of celecoxib]. Schmidt H; Geisslinger G Pharm Unserer Zeit; 2002; 31(2):180-7. PubMed ID: 11977454 [No Abstract] [Full Text] [Related]